Clinical trial
Caffeine Versus Probiotic as Adjuvant Therapy for Preterm Neonates With Bronchopulmonary Dysplasia
NCT05682807 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Caffeine Versus Probiotic as Adjuvant Therapy for Preterm Neonates With Bronchopulmonary Dysplasia
- Lead sponsor
- Tanta University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- June 30, 2022
- Completion date
- June 30, 2025
- Enrollment
- 90 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.